FAST NEWS: Fosun Pharma hits pause button on share buyback program
The Latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday it hasn't yet implemented a share buyback since announcing a plan on March 27 to buy back its A shares…
Genuine Biotech Seeks IPO Booster from New Oral Covid Drug
Company hopes China’s approval of its small molecule oral Covid-19 drug will draw investors to its newly filed listing plan Key Takeaways: Genuine Biotech has filed to list in Hong…
Recent Articles
RELATED ARTICLES
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG -
Fosun International on cusp of new ‘asset-light’ era with latest sale
0656.HK
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism’s post-Covid holiday fizzles
1992.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
